MCID: RNL097
MIFTS: 43

Renal Artery Disease malady

Categories: Cardiovascular diseases, Nephrological diseases

Aliases & Classifications for Renal Artery Disease

Aliases & Descriptions for Renal Artery Disease:

Name: Renal Artery Disease 12 14 69
Vascular Disorder of Kidney 12
Renal Vascular Disorder 69
Renal Vascular Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2388
ICD9CM 35 593.81
NCIt 47 C35338
UMLS 69 C0268790

Summaries for Renal Artery Disease

MalaCards based summary : Renal Artery Disease, also known as vascular disorder of kidney, is related to hypotrichosis simplex and hyperinsulinemic hypoglycemia, familial, 3. An important gene associated with Renal Artery Disease is REN (Renin), and among its related pathways/superpathways are p70S6K Signaling and Peptide hormone metabolism. The drugs Dopamine and Fenoldopam have been mentioned in the context of this disorder. Affiliated tissues include kidney and heart, and related phenotypes are cardiovascular system and adipose tissue

Related Diseases for Renal Artery Disease

Diseases related to Renal Artery Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 98)
id Related Disease Score Top Affiliating Genes
1 hypotrichosis simplex 10.2 ACE REN
2 hyperinsulinemic hypoglycemia, familial, 3 10.2 ACE REN
3 carbohydrate metabolic disorder 10.2 ACE REN
4 hypothyroidism, congenital nongoitrous, 5 10.2 ACE REN
5 listeriosis 10.2 ACE REN
6 dientamoebiasis 10.2 ACE REN
7 congenital nystagmus 10.2 ACE REN
8 penile cancer, childhood 10.2 ACE AGT
9 artery disease 10.2
10 chylocele of tunica vaginalis 10.2 ACE REN
11 microphthalmia, isolated, with coloboma 7 10.1 ACE REN
12 malignant hyperthermia susceptibility 1 10.1 ACE AGT
13 pulmonary valve insufficiency 10.1 ACE REN
14 hypoaldosteronism, congenital, due to cmo i deficiency 10.1 AGT REN
15 kartagener syndrome 10.1 ACE NOS3
16 hypertrichosis of eyelid 10.1 ACE AGTR1
17 mental retardation hypocupremia hypobetalipoproteinemia 10.1 AGT AGTR1
18 villous adenoma 10.1 ACE NOS3
19 episodic kinesigenic dyskinesia 2 10.1 AGT REN
20 aphasia 10.1 ACE NOS3
21 aorta angiosarcoma 10.1 ACE REN
22 deafness, autosomal recessive 79 10.1 ACE REN
23 capillary hemangioma 10.1 NOS3 REN
24 focal dystonia 10.1 ACE NOS3
25 inferolateral myocardial infarct 10.0 ACE NPPA
26 oppositional defiant disorder 10.0 ACE NOS3
27 syringomelia hyperkeratosis 10.0 ACE NPPA
28 shaken baby syndrome 10.0 NPPA REN
29 iida kannari syndrome 10.0 ACE NPPA
30 achromatopsia 10.0 NPPA REN
31 suppurative otitis media 10.0 ACE NPPA
32 petrositis 10.0 ACE AGTR1 REN
33 schizotypal personality disorder 10.0 ACE AGT REN
34 mixed germ cell-sex cord neoplasm 10.0 ACE AGTR1 REN
35 calcinosis 10.0 ACE AGTR1 REN
36 cervix small cell carcinoma 10.0 ACE AGTR1 REN
37 chronic myocardial ischemia 10.0 ACE AGT REN
38 preaxial polydactyly of fingers 10.0 ACE AGT AGTR1
39 viral hepatitis 10.0 ACE NOS3
40 cetp-related hyperalphalipoproteinemia 10.0 ACE AGT AGTR1
41 agammaglobulinemia 6 10.0 ACE AGT AGTR1
42 laryngostenosis 10.0 ACE AGT AGTR1
43 hemorrhagic cystitis 10.0 AGTR1 REN
44 systolic heart failure 10.0 ACE AGT AGTR1
45 familial nephrotic syndrome 10.0 ACE AGT AGTR1
46 limb ischemia 10.0 ACE NOS3 REN
47 diabetic encephalopathy 10.0 ACE NOS3 REN
48 gastrointestinal lymphoma 10.0 ACE NOS3 REN
49 urinary bladder posterior wall cancer 10.0 NPPA REN
50 histidine metabolism disease 10.0 NOS3 NPPA

Comorbidity relations with Renal Artery Disease via Phenotypic Disease Network (PDN): (show all 15)


Acute Cystitis Acute Kidney Failure
Chronic Kidney Failure Chronic Myocardial Ischemia
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Hypertension, Essential
Intermediate Coronary Syndrome Ischemic Heart Disease
Kidney Disease Malignant Renovascular Hypertension
Mitral Valve Disease Peripheral Vascular Disease
Renal Artery Atheroma

Graphical network of the top 20 diseases related to Renal Artery Disease:



Diseases related to Renal Artery Disease

Symptoms & Phenotypes for Renal Artery Disease

MGI Mouse Phenotypes related to Renal Artery Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.8 REN ACE AGT AGTR1 NOS3 NPPA
2 adipose tissue MP:0005375 9.67 ACE AGT AGTR1 NOS3
3 hematopoietic system MP:0005397 9.65 NPPA REN ACE AGTR1 NOS3
4 homeostasis/metabolism MP:0005376 9.63 REN ACE AGT AGTR1 NOS3 NPPA
5 muscle MP:0005369 9.26 REN AGT NOS3 NPPA
6 renal/urinary system MP:0005367 9.1 REN ACE AGT AGTR1 NOS3 NPPA

Drugs & Therapeutics for Renal Artery Disease

Drugs for Renal Artery Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 665)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-61-6, 62-31-7 681
2
Fenoldopam Approved Phase 4 67227-56-9, 67227-57-0 3341
3
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
4
Ticlopidine Approved Phase 4,Phase 3,Phase 2 55142-85-3 5472
5
Candesartan Approved Phase 4,Phase 3 139481-59-7 2541
6
Enalapril Approved, Vet_approved Phase 4,Phase 2,Phase 3 75847-73-3 5362032 40466924
7
Enalaprilat Approved Phase 4,Phase 2,Phase 3 76420-72-9 6917719
8
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
9
Valsartan Approved, Investigational Phase 4,Phase 3 137862-53-4 60846
10
Spironolactone Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1952-01-7, 52-01-7 5833
11
Amlodipine Approved Phase 4,Phase 3,Phase 2,Early Phase 1 88150-42-9 2162
12
Losartan Approved Phase 4,Phase 3,Phase 2,Early Phase 1 114798-26-4 3961
13
Alendronate Approved Phase 4 121268-17-5, 66376-36-1 2088
14
Febuxostat Approved Phase 4 144060-53-7 134018
15
Nitric Oxide Approved Phase 4,Phase 3,Phase 2 10102-43-9 145068
16
Nitroglycerin Approved, Investigational Phase 4,Phase 3 55-63-0 4510
17
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
18
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 2 79217-60-0, 59865-13-3 5284373 6435893
19
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
20
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
21
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
22
Daclizumab Approved, Investigational Phase 4 152923-56-3
23
Acetylcysteine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 616-91-1 12035
24
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 58-61-7 60961
25
Nifedipine Approved Phase 4,Phase 2,Phase 1 21829-25-4 4485
26
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 772 46507594
27
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128794-94-5 5281078
28
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 24280-93-1 446541
29
Ticagrelor Approved Phase 4,Phase 3,Phase 1,Phase 2 274693-27-5 9871419
30
Bisoprolol Approved Phase 4 66722-44-9 2405
31
Isosorbide Dinitrate Approved Phase 4,Phase 3 87-33-2 6883
32
Pioglitazone Approved, Investigational Phase 4,Phase 3 111025-46-8 4829
33
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 2 37350-58-6, 51384-51-1 4171
34
Nebivolol Approved, Investigational Phase 4 152520-56-4, 99200-09-6, 118457-14-0 71301
35
Epoprostenol Approved Phase 4,Phase 3 61849-14-7, 35121-78-9 5280427 5282411
36
Calcium acetate Approved Phase 4 62-54-4
37
Sevelamer Approved Phase 4,Phase 2 52757-95-6, 152751-57-0 3085017
38
Dalteparin Approved Phase 4,Phase 3 9041-08-1
39
Dobutamine Approved Phase 4,Phase 3,Phase 2 34368-04-2 36811
40
Ephedrine Approved Phase 4,Phase 1 299-42-3 9294
41
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-41-2 439260
42
Oxymetazoline Approved Phase 4,Phase 1 1491-59-4 4636
43
Phenylephrine Approved Phase 4,Phase 1 59-42-7 6041
44
Pseudoephedrine Approved Phase 4,Phase 1 90-82-4 7028
45
Regadenoson Approved Phase 4 313348-27-5 219024
46
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
47
Remifentanil Approved Phase 4 132875-61-7 60815
48
Bivalirudin Approved, Investigational Phase 4 128270-60-0 16129704
49
Cilostazol Approved Phase 4 73963-72-1 2754
50
Atenolol Approved Phase 4,Phase 3,Early Phase 1 29122-68-7 2249

Interventional clinical trials:

(show top 50) (show all 1185)
id Name Status NCT ID Phase
1 Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis Unknown status NCT00711984 Phase 4
2 Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Unknown status NCT01023373 Phase 4
3 Fenoldopam for Prevention of Acute Kidney Injury Unknown status NCT01690832 Phase 4
4 Far Infrared Therapy on Peripheral Artery Disease in Hemodialysis Patients Unknown status NCT01095549 Phase 4
5 Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients Unknown status NCT01101698 Phase 4
6 Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS Study) Unknown status NCT01208714 Phase 4
7 Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease Unknown status NCT00235287 Phase 4
8 Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Unknown status NCT00584350 Phase 4
9 Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE) Unknown status NCT02154854 Phase 4
10 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4
11 Effects of Spironolactone in Dialysis Unknown status NCT01128101 Phase 4
12 Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. Unknown status NCT02087332 Phase 4
13 Hypertension Control Based on Home Blood Pressure Unknown status NCT00198562 Phase 4
14 Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes Unknown status NCT01978405 Phase 4
15 Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? Unknown status NCT00299572 Phase 4
16 The Effect of Uric Acid Lowering in Type 1 Diabetes Unknown status NCT02344602 Phase 4
17 Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU) Unknown status NCT01319643 Phase 4
18 Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure Unknown status NCT00716573 Phase 4
19 Fibrosis in Renal Allografts Unknown status NCT00493194 Phase 4
20 The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients Unknown status NCT00247507 Phase 4
21 A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment Completed NCT00863707 Phase 4
22 Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery Completed NCT00244530 Phase 4
23 Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography Completed NCT00209430 Phase 4
24 Renal Artery Contrast-Free Trial Completed NCT01576835 Phase 4
25 A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery Completed NCT02113150 Phase 4
26 Antithrombotic Regimens and Outcome Completed NCT00448461 Phase 4
27 RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography Completed NCT00247325 Phase 4
28 Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease Completed NCT01328470 Phase 4
29 Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide Completed NCT00823628 Phase 4
30 Austrian Multivessel Taxus-Stent Registry Completed NCT00738686 Phase 4
31 Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery. Completed NCT00724880 Phase 4
32 Invasive vs Conservative Strategies in Non-ST-elevation Acute Coronary Syndrome and Comorbidities Completed NCT01645943 Phase 4
33 INVEST: INternational VErapamil SR Trandolapril STudy Completed NCT00133692 Phase 4
34 Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance Completed NCT00129233 Phase 4
35 Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients Completed NCT01336296 Phase 4
36 Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease Completed NCT00431249 Phase 4
37 Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease Completed NCT00395382 Phase 4
38 Antithrombotic Triple Therapy in Humans Completed NCT01812200 Phase 4
39 Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST) Completed NCT00390585 Phase 4
40 Vitamin D and Coronary Calcification Study Completed NCT00752102 Phase 4
41 Renal Denervation in Diabetic Nephropathy Completed NCT01588795 Phase 4
42 Lupus Atherosclerosis Prevention Study Completed NCT00120887 Phase 4
43 ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis Completed NCT00379899 Phase 4
44 Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial Completed NCT01123291 Phase 4
45 China Medical University Hospital (CMUH) Triapin Listing Completed NCT00841880 Phase 4
46 Parathyroidectomy in Endstage Renal Disease Completed NCT00745719 Phase 4
47 Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)? Completed NCT01295567 Phase 4
48 Arterial pH and N-balances in APD Completed NCT00586131 Phase 4
49 A Trial of Telmisartan Prevention of Cardiovascular Disease Completed NCT01075698 Phase 4
50 Zainidip in Renal Artery Stenosis Completed NCT02594410 Phase 4

Search NIH Clinical Center for Renal Artery Disease

Genetic Tests for Renal Artery Disease

Anatomical Context for Renal Artery Disease

MalaCards organs/tissues related to Renal Artery Disease:

39
Kidney, Heart

Publications for Renal Artery Disease

Articles related to Renal Artery Disease:

(show all 25)
id Title Authors Year
1
Renovascular heart failure: heart failure in patients with atherosclerotic renal artery disease. ( 27052017 )
2016
2
Our preoccupation with renal artery disease in patients undergoing cardiac surgery: much ado about nothing? ( 24161327 )
2014
3
Prevalence of renal artery disease and its prognostic significance in patients undergoing coronary bypass grafting. ( 25150754 )
2014
4
Ex vivo renal artery reconstruction for complex renal artery disease. ( 24594447 )
2014
5
Long-term follow-up of patients with atherosclerotic renal artery disease. ( 23321402 )
2013
6
Vanishing renal artery disease: a segmental arterial mediolysis story. ( 21997510 )
2011
7
Endovascular and open revascularization for nonatherosclerotic renal artery disease. ( 21249718 )
2011
8
MD CT angiography and MR angiography of nonatherosclerotic renal artery disease. ( 21681628 )
2011
9
Atherosclerotic renal artery disease and heart failure: questions in mind. ( 20466691 )
2010
10
Late outcomes of endovascular and open revascularization for nonatherosclerotic renal artery disease. ( 20855752 )
2010
11
Update on the management of atherosclerotic renal artery disease. ( 19202521 )
2009
12
A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease. ( 17499952 )
2008
13
Atherosclerotic Peripheral Vascular Disease Symposium II: intervention for renal artery disease. ( 19106410 )
2008
14
Low frequency of renal artery disease in young ischemic stroke patients. ( 18564822 )
2008
15
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography. ( 19110812 )
2008
16
Novel stent system for accurate placement in aorto-ostial renal artery disease: preclinical study in porcine renal artery model. ( 17574168 )
2007
17
Clinical insights into the diagnosis and management of atherosclerotic renal artery disease. ( 16901412 )
2006
18
Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease. ( 16892443 )
2006
19
Surgical revascularization for renal artery disease: current status. ( 15720339 )
2005
20
Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography. ( 16310572 )
2005
21
Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease. ( 16208147 )
2005
22
Genetic risk of atherosclerotic renal artery disease: the candidate gene approach in a renal angiography cohort. ( 15326089 )
2004
23
Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. ( 8272217 )
1993
24
Effect of captopril on the renal veno-arterial gradient of erythropoietin and oxygen in unilateral renal artery disease. ( 8140397 )
1993
25
The effect of caffeine on renal vein renin concentration in patients with renal arterial disease. ( 1815652 )
1991

Variations for Renal Artery Disease

Expression for Renal Artery Disease

Search GEO for disease gene expression data for Renal Artery Disease.

Pathways for Renal Artery Disease

GO Terms for Renal Artery Disease

Cellular components related to Renal Artery Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 8.92 ACE AGT NPPA REN

Biological processes related to Renal Artery Disease according to GeneCards Suite gene sharing:

(show all 32)
id Name GO ID Score Top Affiliating Genes
1 female pregnancy GO:0007565 9.65 AGT NPPA
2 regulation of cell growth GO:0001558 9.65 AGT AGTR1
3 cellular response to mechanical stimulus GO:0071260 9.65 AGT NPPA
4 phospholipase C-activating G-protein coupled receptor signaling pathway GO:0007200 9.64 AGT AGTR1
5 positive regulation of inflammatory response GO:0050729 9.64 AGT AGTR1
6 regulation of cardiac conduction GO:1903779 9.63 AGT NPPA
7 positive regulation of reactive oxygen species metabolic process GO:2000379 9.63 AGT AGTR1
8 positive regulation of protein tyrosine kinase activity GO:0061098 9.62 ACE AGT
9 positive regulation of vasodilation GO:0045909 9.62 AGT NOS3
10 kidney development GO:0001822 9.62 ACE AGT AGTR1 REN
11 vasodilation GO:0042311 9.61 AGT NOS3
12 nitric oxide mediated signal transduction GO:0007263 9.61 AGT NOS3
13 blood vessel remodeling GO:0001974 9.61 ACE AGT NOS3
14 positive regulation of cellular protein metabolic process GO:0032270 9.6 AGT AGTR1
15 positive regulation of macrophage derived foam cell differentiation GO:0010744 9.59 AGT AGTR1
16 beta-amyloid metabolic process GO:0050435 9.58 ACE REN
17 regulation of vasodilation GO:0042312 9.58 ACE AGTR1
18 regulation of vasoconstriction GO:0019229 9.58 ACE AGT AGTR1
19 low-density lipoprotein particle remodeling GO:0034374 9.57 AGT AGTR1
20 regulation of blood vessel diameter GO:0097746 9.56 ACE AGTR1
21 positive regulation of cholesterol esterification GO:0010873 9.55 AGT AGTR1
22 cell growth involved in cardiac muscle cell development GO:0061049 9.54 AGT NPPA
23 regulation of blood vessel size GO:0050880 9.54 AGT NOS3 NPPA
24 positive regulation of NAD(P)H oxidase activity GO:0033864 9.52 AGT AGTR1
25 regulation of renal sodium excretion GO:0035813 9.51 AGT AGTR1
26 regulation of blood volume by renin-angiotensin GO:0002016 9.49 AGT REN
27 regulation of blood vessel diameter by renin-angiotensin GO:0002034 9.48 AGT AGTR1
28 regulation of renal output by angiotensin GO:0002019 9.46 ACE AGT
29 angiotensin maturation GO:0002003 9.43 ACE AGT REN
30 regulation of systemic arterial blood pressure by renin-angiotensin GO:0003081 9.33 ACE AGT AGTR1
31 renin-angiotensin regulation of aldosterone production GO:0002018 9.13 AGT AGTR1 REN
32 regulation of blood pressure GO:0008217 9.02 ACE AGT NOS3 NPPA REN

Molecular functions related to Renal Artery Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 endopeptidase activity GO:0004175 8.96 ACE REN
2 bradykinin receptor binding GO:0031711 8.62 ACE AGTR1

Sources for Renal Artery Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....